@oncotelic.com
Oncotelic is a cancer immunotherapy company
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Oncotelic Therapeutics is a leading biopharmaceutical and AI technology company that specializes in the development of innovative therapies for various diseases, including cancer. With a team of experienced professionals and experts, Oncotelic is dedicated to advancing the field of biomedicine and improving patient outcomes. Led by CEO Vuong Trieu, PhD, who has a strong background in pharmaceutical development, the company has made significant contributions to the industry.
Previously, Dr. Trieu played a key role in the approval of paclitaxel nanomedicine through a single bioequivalence trial, revolutionizing the pharmaceutical regulatory pathway. Oncotelic offers a wide range of products and services, with a focus on immunotherapy for cancer and infectious diseases.
Their Chief Clinical Officer, Anthony E. Maida III, PhD, has been instrumental in the development of immunotherapies and has extensive experience in clinical research. Additionally, Oncotelic's Chief Medical Officer, Seymour Fein, MD, brings over 35 years of expertise in drug development research.
His contributions have led to the successful FDA approvals of over 20 drugs and medical devices. With their commitment to innovation and patient care, Oncotelic is at the forefront of revolutionizing the field of biopharmaceuticals, offering hope and new treatment options for patients worldwide
Company Type
Public Company
Company Size
11-50
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories